Ottimo

CellmAbs

This biotech company develops monoclonal antibodies and adoptive cell therapies to treat oncology patients with solid tumours.

OverT

This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

OPS-γδ

This company develops an engineered gamma delta T cell therapy platform to treat patients with solid tumours.

VelaVigo

This biotechnology company develops multi-specific antibodies and antibody-drug conjugates for patients with cancer and autoimmune diseases.

Tacalyx

This company develops antibody-based therapeutics targeting tumour associated carbohydrate antigens for the treatment of solid tumours in cancer patients.

IO Biotech

The company develops immune-modulating therapeutic cancer vaccines to treat patients with melanoma and other solid tumours.

Adaptam Therapeutics

Adaptam Therapeutics develops antibody-based therapies for solid tumours to treat oncology patients by targeting immunosuppressive myeloid cells.